DNAシーケンス市場：製品・サービス、技術、ワークフロー、アプリケーション別-2025-2030年世界予測

DNAシーケンス市場は、2023年に603億9,000万米ドルと評価され、2024年には719億8,000万米ドルに達すると予測され、CAGR 19.51％で成長し、2030年には2,103億4,000万米ドルに達すると予測されています。

DNAシーケンスは、主にヘルスケア、バイオテクノロジー、農業、法医学など、複数の分野で極めて重要な最先端技術です。DNAシーケンスの範囲は、ゲノム研究、疾病診断、個別化医療、遺伝子工学などの広大なアプリケーションを包含しています。ヘルスケアでは、正確なゲノムの洞察を通じて、遺伝性疾患、がん、感染症の早期発見と治療に不可欠なツールです。農業分野では、作物の回復力と生産性を向上させることでDNAシーケンスの恩恵を受けており、科学捜査分野では、身元確認や犯罪捜査に活用されています。市場成長を促進する主な要因としては、シーケンス技術の進歩、シーケンスコストの低下、ゲノム研究に対する政府および民間投資の急増などが挙げられます。さらに、慢性疾患の蔓延が進んでいるため、堅牢な診断ソリューションが必要とされており、その精度と信頼性の高さからDNAシーケンスが最前線にあります。しかし、市場の成長は倫理的な懸念、厳しい規制の枠組み、データ・プライバシーの問題などの制約に直面しています。データ解釈の複雑さや熟練した専門家の不足が、さらに状況を複雑にしています。とはいえ、ポータブルシーケンスデバイス、自動データ解析ソリューション、データ保存・共有のためのクラウドベースのプラットフォームなど、開発機会は豊富にあります。また、未開拓の可能性とヘルスケアインフラ投資の増加により、企業は新興国での事業拡大も視野に入れています。イノベーションの焦点は、シーケンシングのスピードと精度の向上、より優れたデータ分析のためのAIの統合、アクセシビリティと普及を拡大するためのコスト効率の確保であろう。市場情勢は本質的にダイナミックであり、継続的な技術の進歩と規制状況の進化に後押しされています。競争力を維持するには、戦略的パートナーシップ、研究開発への投資、新たな倫理的ガイドラインの遵守が必要です。精密医療が普及し、予測分析のための機械学習が採用され、合成生物学が探求されることで、画期的なアプリケーションと市場拡大の道が開かれる可能性があります。その結果、イノベーションと倫理的慣行や規制遵守のバランスを取ることができる企業にとっては、成長への明確な道筋が見えてくる。

市場力学：急速に進化するDNAシーケンス市場の主要市場インサイトを公開

DNAシーケンス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界中で増加する遺伝性疾患の症例
  • コンパニオン診断と個別化医療におけるNGSの役割の増大
  • アグリゲノミクスと法医学におけるDNAシーケンスの使用量の増加
• 市場抑制要因
  • DNAシーケンスに関連する技術的限界
• 市場機会
  • DNAシーケンスの進歩と発展
  • DNAシーケンスおよびシングルセルシーケンスへの投資の増加
• 市場の課題
  • DNAシーケンスの精度、信頼性、倫理的意味合いに関する問題

ポーターの5つの力：DNAシーケンス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、DNAシーケンス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：DNAシーケンス市場における外部からの影響の把握

外部マクロ環境要因は、DNAシーケンス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析DNAシーケンス市場における競合情勢の把握

DNAシーケンス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスDNAシーケンス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、DNAシーケンス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で遺伝性疾患の症例が増加
    • コンパニオン診断と個別化医療におけるNGSの役割の増大
    • 農業ゲノム科学と法医学におけるDNAシーケンスの使用増加
  • 抑制要因
    • DNAシーケンスに関連する技術的な制限
  • 機会
    • DNAシーケンスの進歩と発展
    • DNAシーケンスと単一細胞シーケンシングへの投資増加
  • 課題
    • DNAシーケンスの正確性、信頼性、倫理的影響に関連する問題
• 市場セグメンテーション分析
  • 製品とサービス：バイオインフォマティクスと計算生物学の進歩によるサービス全体の進化
  • テクノロジー：超高スループットを実現する次世代シーケンシング（NGS）の人気の高まり
  • ワークフロー：精度要件を満たすためのシーケンス方法の好感度が高まっている
  • 応用：遺伝性疾患の正確な診断と理解のための臨床調査におけるDNAシーケンスの応用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 DNAシーケンス市場製品とサービス別

• 消耗品
• 機器
• サービス

第7章 DNAシーケンス市場：技術別

• 次世代シーケンシング
  • ターゲットシーケンシングとリシーケンシング
  • 全エクソーム配列解析
  • 全ゲノム配列解析
• サンガーシーケンス
• 第三世代DNAシーケンス
  • ナノポアシーケンシング
  • 単一分子リアルタイムシーケンシング

第8章 DNAシーケンス市場：ワークフロー別

• データ分析
• 事前シーケンス
• シーケンシング

第9章 DNAシーケンス市場：用途別

• アグリゲノミクスと法医学
• 臨床調査
• 消費者ゲノミクス
• HLAタイピングまたは免疫システムモニタリング
• メタゲノミクス、疫学、医薬品開発
• 腫瘍学
• 生殖に関する健康

第10章 南北アメリカのDNAシーケンス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のDNAシーケンス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのDNAシーケンス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Ultima Genomics、100ドルでゲノムを解読できる高性能DNAシーケンサーを発売
  • 4,630万ポンドの資金調達で闇ゲノムに光を当てる
  • BDとハミルトンがロボットを使った単一細胞マルチオミクス実験の標準化に協力
  • オックスフォードナノポア、多様な顧客タイプに包括的なゲノムデータを提供するためのシンプレックス単一分子精度のパフォーマンスを発表
  • エレメント・バイオサイエンス社とアジレント・テクノロジーズが提携を拡大し、製品ポートフォリオを拡大
  • アライアンスはナノポアライブラリの準備を自動化して革命を起こすことを望んでいる
  • TecanとOxford NanoporeがLong Fragment DNAシーケンスで提携
  • UPSヘルスケアとオックスフォードナノポアが提携し、アジア太平洋地域にDNAシーケンステクノロジーを提供
  • NIHソフトウェアがオンデマンドで完全なゲノム配列を組み立てる
  • ユーロフィンズ・ゲノミクス米国、即日結果が出るエクスプレス・オックスフォード・ナノポア・シーケンシング・サービスを開始
  • QIAGEN Digital Insightsは、クラウドコンピューティングコスト1ドルでゲノム全体を25分で処理できる超高速NGS分析を開始しました。
  • 英国、タイとの画期的な提携を通じてゲノム科学の専門知識を強化へ
  • Complete Genomics、バイオテクノロジーショーケースでフルシーケンシングプラットフォームを発表2023
  • イルミナ、分子残存病変がん検査の進歩に向けヤンセンとの提携を拡大
  • アジレントがアビダ・バイオメッドを買収、がん調査のための次世代シーケンシングを強化
  • エレメントバイオサイエンスが新しいDNAシーケンス機器、化学を発表

企業一覧

• 10x Genomics, Inc.
• Abbott Laboratories
• AbbVie Inc.
• Agilent Technologies, Inc.
• Azenta, Inc.
• Becton, Dickinson and Company
• BGI Genomics Co., Ltd.
• Bio-Rad Laboratories, Inc.
• BioChain Institute Inc.
• Charles River Laboratories International, Inc.
• Danaher Corporation
• Dante Labs Inc.
• Eppendorf SE
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• Genomics England
• Genscript Biotech Corporation
• Illumina, Inc.
• Johnson & Johnson Services, Inc.
• Konica Minolta, Inc.
• Laboratory Corporation of America Holdings
• Macrogen Inc.
• Merck KGaA
• Novartis AG
• Novogene Co, Ltd.
• Oxford Nanopore Technologies PLC
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• QIAGEN N.V.
• Sartorius AG
• Shimadzu Corporation
• SOPHiA GENETICS SA
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation
• Veritas Genetics Inc. by LetsGetChecked

LIST OF FIGURES

• FIGURE 1. DNA SEQUENCING MARKET RESEARCH PROCESS
• FIGURE 2. DNA SEQUENCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DNA SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES DNA SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES DNA SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. DNA SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. DNA SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DNA SEQUENCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DNA SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DNA SEQUENCING MARKET DYNAMICS
• TABLE 7. GLOBAL DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DNA SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DNA SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DNA SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RESEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DNA SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DNA SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DNA SEQUENCING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DNA SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DNA SEQUENCING MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DNA SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DNA SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DNA SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DNA SEQUENCING MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DNA SEQUENCING MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DNA SEQUENCING MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DNA SEQUENCING MARKET SIZE, BY HLA TYPING OR IMMUNE SYSTEM MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DNA SEQUENCING MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DNA SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL DNA SEQUENCING MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. CANADA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 54. CANADA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. CANADA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 56. CANADA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 57. CANADA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 58. CANADA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES DNA SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. CHINA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 86. CHINA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. CHINA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 88. CHINA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 89. CHINA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 90. CHINA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. INDIA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 92. INDIA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. INDIA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 94. INDIA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 95. INDIA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 96. INDIA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. ITALY DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 195. ITALY DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. ITALY DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 197. ITALY DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 198. ITALY DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 199. ITALY DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. POLAND DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 219. POLAND DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 220. POLAND DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 221. POLAND DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 222. POLAND DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 223. POLAND DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. QATAR DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 225. QATAR DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 226. QATAR DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 227. QATAR DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 228. QATAR DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 229. QATAR DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM DNA SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM DNA SEQUENCING MARKET SIZE, BY THIRD GENERATION DNA SEQUENCING, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM DNA SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 284. DNA SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 285. DNA SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

The DNA Sequencing Market was valued at USD 60.39 billion in 2023, expected to reach USD 71.98 billion in 2024, and is projected to grow at a CAGR of 19.51%, to USD 210.34 billion by 2030.

DNA sequencing is a cutting-edge technology pivotal in multiple sectors, primarily healthcare, biotechnology, agriculture, and forensic sciences. The scope of DNA sequencing encompasses vast applications such as genomic research, disease diagnosis, personalized medicine, and genetic engineering. In healthcare, it is a crucial tool for early detection and treatment of genetic disorders, cancer, and infectious diseases through precise genomic insights. Agriculture benefits from DNA sequencing by improving crop resilience and productivity while forensics utilizes it for identity verification and criminal investigations. Key factors driving market growth include advancements in sequencing technologies, declining sequencing costs, and surged governmental and private investment in genomics research. Additionally, the rising prevalence of chronic diseases necessitates robust diagnostic solutions, with DNA sequencing at the forefront due to its precision and reliability. However, market growth faces limitations such as ethical concerns, stringent regulatory frameworks, and data privacy issues. The complexity of data interpretation and lack of skilled professionals further complicate the landscape. Nevertheless, opportunities abound in developing portable sequencing devices, automated data analysis solutions, and cloud-based platforms for data storage and sharing. Companies are also poised to expand in emerging economies due to untapped potential and increased healthcare infrastructure investments. Innovation could focus on enhancing sequencing speed and accuracy, integrating AI for better data analytics, and ensuring cost-efficiency to widen accessibility and adoption. The DNA sequencing market is inherently dynamic, driven by continuous technological advancements and evolving regulatory landscapes. Staying competitive demands strategic partnerships, investment in R&D, and adherence to emerging ethical guidelines. With precision medicine gaining traction, embracing machine learning for predictive analytics, and exploring synthetic biology could pave the way for groundbreaking applications and market expansions. Consequently, the market remains promising yet challenging, with a clear path to growth for those who can balance innovation with ethical practices and regulatory compliance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA Sequencing Market

The DNA Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing cases of genetic disorders across the world
  • Increasing role of NGS in companion diagnostics and personalized medicines
  • Growing usage of DNA sequencing across agrigenomics and forensics
• Market Restraints
  • Technical limitations associated with DNA sequencing
• Market Opportunities
  • Advancements and developments in DNA sequencing
  • Rising investments in DNA sequencing and single-cell sequencing
• Market Challenges
  • Issues associated with the accuracy, reliability, and ethical implications of DNA sequencing

Porter's Five Forces: A Strategic Tool for Navigating the DNA Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA Sequencing Market

A detailed market share analysis in the DNA Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the DNA Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc., Azenta, Inc., Becton, Dickinson and Company, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., BioChain Institute Inc., Charles River Laboratories International, Inc., Danaher Corporation, Dante Labs Inc., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Genomics England, Genscript Biotech Corporation, Illumina, Inc., Johnson & Johnson Services, Inc., Konica Minolta, Inc., Laboratory Corporation of America Holdings, Macrogen Inc., Merck KGaA, Novartis AG, Novogene Co, Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Sartorius AG, Shimadzu Corporation, SOPHiA GENETICS SA, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Veritas Genetics Inc. by LetsGetChecked.

Market Segmentation & Coverage

This research report categorizes the DNA Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Services, market is studied across Consumables, Instruments, and Services.
• Based on Technology, market is studied across Next-Generation Sequencing, Sanger Sequencing, and Third Generation DNA Sequencing. The Next-Generation Sequencing is further studied across Targeted Sequencing & Resequencing, Whole Exome Sequencing, and Whole Genome Sequencing. The Third Generation DNA Sequencing is further studied across Nanopore Sequencing and Single-Molecule Real-Time Sequencing.
• Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
• Based on Application, market is studied across Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing or Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Oncology, and Reproductive Health.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of genetic disorders across the world
    • 5.1.1.2. Increasing role of NGS in companion diagnostics and personalized medicines
    • 5.1.1.3. Growing usage of DNA sequencing across agrigenomics and forensics
  • 5.1.2. Restraints
    • 5.1.2.1. Technical limitations associated with DNA sequencing
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements and developments in DNA sequencing
    • 5.1.3.2. Rising investments in DNA sequencing and single-cell sequencing
  • 5.1.4. Challenges
    • 5.1.4.1. Issues associated with the accuracy, reliability, and ethical implications of DNA sequencing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product & Services: Evolution across services with advances in bioinformatics and computational biology
  • 5.2.2. Technology: Growing popularity of next-generation sequencing (NGS) for ultra-high throughput
  • 5.2.3. Workflow: Rising preference for sequencing methods to meet accuracy requirements
  • 5.2.4. Application: Expanding application of DNA sequencing in clinical investigation for precise diagnosis and understanding of genetic disorders
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. DNA Sequencing Market, by Product & Services

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instruments
• 6.4. Services

7. DNA Sequencing Market, by Technology

• 7.1. Introduction
• 7.2. Next-Generation Sequencing
  • 7.2.1. Targeted Sequencing & Resequencing
  • 7.2.2. Whole Exome Sequencing
  • 7.2.3. Whole Genome Sequencing
• 7.3. Sanger Sequencing
• 7.4. Third Generation DNA Sequencing
  • 7.4.1. Nanopore Sequencing
  • 7.4.2. Single-Molecule Real-Time Sequencing

8. DNA Sequencing Market, by Workflow

• 8.1. Introduction
• 8.2. Data Analysis
• 8.3. Pre-Sequencing
• 8.4. Sequencing

9. DNA Sequencing Market, by Application

• 9.1. Introduction
• 9.2. Agrigenomics & Forensics
• 9.3. Clinical Investigation
• 9.4. Consumer Genomics
• 9.5. HLA Typing or Immune System Monitoring
• 9.6. Metagenomics, Epidemiology & Drug Development
• 9.7. Oncology
• 9.8. Reproductive Health

10. Americas DNA Sequencing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific DNA Sequencing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa DNA Sequencing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Ultima Genomics Launching High-end DNA Sequencers that can Read Genome for USD 100
  • 13.3.2. GBP 46.3 Million Funding Boost to Shine Light on Dark Genome
  • 13.3.3. BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
  • 13.3.4. Oxford Nanopore Announces Performance in Simplex Single Molecule Accuracy to Provide Comprehensive Genomic Data for Diverse Customer Types
  • 13.3.5. Element Biosciences Inc. and Agilent Technologies Expand Partnership to Expand Product Portfolio
  • 13.3.6. Alliance Hopes to Automate Nanopore Library Preparation to Revolutionize the DNA Sequencing
  • 13.3.7. Tecan and Oxford Nanopore partnered for Long Fragment DNA Sequencing
  • 13.3.8. UPS Healthcare & Oxford Nanopore partner to deliver DNA sequencing tech across APAC
  • 13.3.9. NIH Software Assembles Complete Genome Sequences On-demand
  • 13.3.10. Eurofins Genomics US Launches Express Oxford Nanopore Sequencing Service with Same-Day Results
  • 13.3.11. QIAGEN Digital Insights launched ultra-fast NGS Analysis Able To Process a Whole Genome In 25 minutes For A USD 1 Cloud Computing Costs
  • 13.3.12. UK Set to Boost Genomics Expertise Through a Landmark Partnership with Thailand
  • 13.3.13. Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase 2023
  • 13.3.14. Illumina Expands Collaboration with Janssen to Advance Molecular Residual Disease Cancer Test
  • 13.3.15. Agilent Acquires Avida Biomed, Boosting Next-generation Sequencing for Cancer Research
  • 13.3.16. Element Biosciences Unveils New DNA Sequencing Instrument, Chemistry

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Abbott Laboratories
• 3. AbbVie Inc.
• 4. Agilent Technologies, Inc.
• 5. Azenta, Inc.
• 6. Becton, Dickinson and Company
• 7. BGI Genomics Co., Ltd.
• 8. Bio-Rad Laboratories, Inc.
• 9. BioChain Institute Inc.
• 10. Charles River Laboratories International, Inc.
• 11. Danaher Corporation
• 12. Dante Labs Inc.
• 13. Eppendorf SE
• 14. Eurofins Scientific SE
• 15. F. Hoffmann-La Roche Ltd.
• 16. Genomics England
• 17. Genscript Biotech Corporation
• 18. Illumina, Inc.
• 19. Johnson & Johnson Services, Inc.
• 20. Konica Minolta, Inc.
• 21. Laboratory Corporation of America Holdings
• 22. Macrogen Inc.
• 23. Merck KGaA
• 24. Novartis AG
• 25. Novogene Co, Ltd.
• 26. Oxford Nanopore Technologies PLC
• 27. Pacific Biosciences of California, Inc.
• 28. PerkinElmer, Inc.
• 29. QIAGEN N.V.
• 30. Sartorius AG
• 31. Shimadzu Corporation
• 32. SOPHiA GENETICS SA
• 33. Thermo Fisher Scientific Inc.
• 34. Twist Bioscience Corporation
• 35. Veritas Genetics Inc. by LetsGetChecked